These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 30056034

  • 1. The development of a bead-based multiplex immunoassay for the detection of IgG antibodies to CMV and EBV.
    Tcherniaeva I, den Hartog G, Berbers G, van der Klis F.
    J Immunol Methods; 2018 Nov; 462():1-8. PubMed ID: 30056034
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of suitable target antigens and immunoassays for high-accuracy immune monitoring of cytomegalovirus and Epstein-Barr virus-specific T cells as targets of interest in immunotherapeutic approaches.
    Tischer S, Dieks D, Sukdolak C, Bunse C, Figueiredo C, Immenschuh S, Borchers S, Stripecke R, Maecker-Kolhoff B, Blasczyk R, Eiz-Vesper B.
    J Immunol Methods; 2014 Jun; 408():101-13. PubMed ID: 24877879
    [Abstract] [Full Text] [Related]

  • 3. Immunoreactivation of Epstein-Barr virus due to cytomegalovirus primary infection.
    Aalto SM, Linnavuori K, Peltola H, Vuori E, Weissbrich B, Schubert J, Hedman L, Hedman K.
    J Med Virol; 1998 Nov; 56(3):186-91. PubMed ID: 9783683
    [Abstract] [Full Text] [Related]

  • 4. Virus-specific antibodies to Epstein-Barr virus, varicella-zoster virus and rubella virus in renal transplant patients with cytomegalovirus infections.
    O'Neill HJ, Shirodaria PV.
    J Infect; 1992 May; 24(3):301-9. PubMed ID: 1318341
    [Abstract] [Full Text] [Related]

  • 5. Evaluation the Architect EBV VCA IgM, VCA IgG, and EBNA-1 IgG chemiluminescent immunoassays to assess EBV serostatus prior transplantation.
    Maylin S, Feghoul L, Salmona M, Herda A, Mercier-Delarue S, Simon F, Legoff J.
    J Med Virol; 2017 Nov; 89(11):2003-2010. PubMed ID: 28661055
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of antibodies to cytomegalovirus and Epstein-Barr virus in patients with autism spectrum disorder.
    Valayi S, Eftekharian MM, Taheri M, Alikhani MY.
    Hum Antibodies; 2017 Nov; 26(3):165-169. PubMed ID: 29689713
    [Abstract] [Full Text] [Related]

  • 7. Cytomegalovirus and Epstein-Barr virus infections in patients with neuromyelitis optica spectrum disorder.
    Shi Z, Kong L, Wang R, Wang X, Wang Z, Luo W, Chen H, Du Q, Sun D, Zhou H.
    J Neurol; 2024 Sep; 271(9):6089-6095. PubMed ID: 39046523
    [Abstract] [Full Text] [Related]

  • 8. Investigation of atypical serological profiles for Epstein-Barr virus (EBV).
    Portet Sulla V, Kadi A, Mouna L, Fenaux H, Cechura H, Rafek R, Di Ciccone JL, Warnakulasuriya F, Vauloup-Fellous C.
    J Virol Methods; 2024 Sep; 329():115002. PubMed ID: 39067186
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of the abbot Architect(™) epstein-barr virus viral capsid antigen IgM, viral capsid antigen IgG and nuclear antigen IgG assays in a pediatric and adult population.
    Grandjean Lapierre S, Vallières E, Rabaamad L, Labrecque M, Chartrand C, Renaud C.
    J Clin Virol; 2016 Aug; 81():1-5. PubMed ID: 27258036
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of a multiplex flow immunoassay for detection of epstein-barr virus-specific antibodies.
    Binnicker MJ, Jespersen DJ, Harring JA, Rollins LO, Beito EM.
    Clin Vaccine Immunol; 2008 Sep; 15(9):1410-3. PubMed ID: 18632919
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of a multiplex fluorescent microsphere immunoassay for the determination of epstein-barr virus serologic status.
    Martins TB, Litwin CM, Hill HR.
    Am J Clin Pathol; 2008 Jan; 129(1):34-41. PubMed ID: 18089487
    [Abstract] [Full Text] [Related]

  • 12. An ELISA method to compute endpoint titers to Epstein-Barr virus and cytomegalovirus: application to population-based studies.
    Stowe RP, Ruiz RJ, Fagundes CP, Stowe RH, Chen M, Glaser R.
    J Immunol Methods; 2014 Jun; 408():64-9. PubMed ID: 24859346
    [Abstract] [Full Text] [Related]

  • 13. Measurement of EBV-IgG anti-VCA avidity aids the early and reliable diagnosis of primary EBV infection.
    Robertson P, Beynon S, Whybin R, Brennan C, Vollmer-Conna U, Hickie I, Lloyd A.
    J Med Virol; 2003 Aug; 70(4):617-23. PubMed ID: 12794726
    [Abstract] [Full Text] [Related]

  • 14. Analytical performance evaluation of the Elecsys Epstein-Barr virus immunoassay panel.
    Schulte-Spechtel U, Berth M, Lauseker-Hao Y, Meyer-Schlinkmann K, Bohnert M, Jochum S, Schuhmann K.
    Diagn Microbiol Infect Dis; 2021 Nov; 101(3):115443. PubMed ID: 34304105
    [Abstract] [Full Text] [Related]

  • 15. EBV VCA IgM and cytomegalovirus IgM dual positivity is a false positive finding related to age and hepatic involvement of primary Epstein-Barr virus infection in children.
    Sohn MJ, Cho JM, Moon JS, Ko JS, Yang HR.
    Medicine (Baltimore); 2018 Sep; 97(38):e12380. PubMed ID: 30235701
    [Abstract] [Full Text] [Related]

  • 16. Serologic Status of Routine Childhood Vaccines, Cytomegalovirus, and Epstein-Barr Virus in Children With Inflammatory Bowel Disease.
    deBruyn JCC, Soon IS, Fonseca K, Feng S, Purtzki M, Goedhart C, Kuhn S, Vanderkooi OG, Wrobel I.
    Inflamm Bowel Dis; 2019 Jun 18; 25(7):1218-1226. PubMed ID: 30551205
    [Abstract] [Full Text] [Related]

  • 17. Epstein-Barr virus and cytomegalovirus in autoimmune diseases: are they truly notorious? A preliminary report.
    Barzilai O, Sherer Y, Ram M, Izhaky D, Anaya JM, Shoenfeld Y.
    Ann N Y Acad Sci; 2007 Jun 18; 1108():567-77. PubMed ID: 17894021
    [Abstract] [Full Text] [Related]

  • 18. Performance of the architect EBV antibody panel for determination of Epstein-Barr virus infection stage in immunocompetent adolescents and young adults with clinical suspicion of infectious mononucleosis.
    Guerrero-Ramos A, Patel M, Kadakia K, Haque T.
    Clin Vaccine Immunol; 2014 Jun 18; 21(6):817-23. PubMed ID: 24695777
    [Abstract] [Full Text] [Related]

  • 19. Epstein-Barr virus but not cytomegalovirus is associated with reduced vaccine antibody responses in Gambian infants.
    Holder B, Miles DJ, Kaye S, Crozier S, Mohammed NI, Duah NO, Roberts E, Ojuola O, Palmero MS, Touray ES, Waight P, Cotten M, Rowland-Jones S, van der Sande M, Whittle H.
    PLoS One; 2010 Nov 17; 5(11):e14013. PubMed ID: 21103338
    [Abstract] [Full Text] [Related]

  • 20. Seroepidemiology of Epstein-Barr virus and cytomegalovirus among Israeli male young adults.
    Levine H, Balicer RD, Rozhavski V, Halperin T, Shreberk M, Davidovitch N, Huerta-Hartal M, Ankol OE.
    Ann Epidemiol; 2012 Nov 17; 22(11):783-8. PubMed ID: 22831994
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.